Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Up 40.4% in January

Applied DNA Sciences, Inc. (NASDAQ:APDN) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 7,060,000 shares, an increase of 40.4% from the December 31st total of 5,030,000 shares. Based on an average daily trading volume, of 5,960,000 shares, the short-interest ratio is presently 1.2 days.

Applied DNA Sciences Stock Performance

Shares of APDN traded down $0.00 during mid-day trading on Friday, reaching $0.18. 512,071 shares of the company’s stock traded hands, compared to its average volume of 3,570,315. The business’s 50-day moving average price is $0.19 and its 200-day moving average price is $0.54. The stock has a market capitalization of $9.71 million, a P/E ratio of -0.03 and a beta of 0.40. Applied DNA Sciences has a 12 month low of $0.12 and a 12 month high of $14.40.

Applied DNA Sciences (NASDAQ:APDN) last posted its quarterly earnings data on Tuesday, December 17th. The technology company reported ($0.32) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.01. Applied DNA Sciences had a negative net margin of 203.76% and a negative return on equity of 111.18%. Equities research analysts anticipate that Applied DNA Sciences will post -0.87 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Applied DNA Sciences stock. Jane Street Group LLC acquired a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned about 0.24% of Applied DNA Sciences at the end of the most recent quarter. Institutional investors and hedge funds own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.